Study identifier:D961OC00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Effect of intravenous esomeprazole versus cimetidine in prevention of Stress Ulcer Prophylaxis in Chinese seriously ill patients - a randomized, double-blind, parallel-group study
Stress Ulcer Prophylaxis
Phase 3
No
Esomeprazole, Cimetidine
All
343
Interventional
18 Years - 70 Years
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Prevention
Verified 01 Mar 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: Esomeprazole active treatment iv esomeprazole 30 min intermittent infusions given for maximum 14 days | Drug: Esomeprazole iv esomeprazole 30 min intermittent infusions given for maximum 14 days Other Name: Nexium |
Active Comparator: Cimetidine active treatment iv cimetidine 30 min bolus infusion followed by iv cimetidine continuous infusion given for maximum 14 days | Drug: Cimetidine iv cimetidine 30 min bolus infusion followed by iv cimetidine continuous infusion given for maximum 14 days Other Name: Tagamet |